Real-world evidence on clinical outcomes of commonly used antidepressants in older adults initiating antidepressants for depression: a nationwide cohort study in …
K Ishtiak-Ahmed, KL Musliner… - American journal of …, 2024 - Am Psychiatric Assoc
Objective: The authors investigated the clinical outcomes of commonly used antidepressants
among older adults who initiated first-time antidepressants for depression by analyzing the 1 …
among older adults who initiated first-time antidepressants for depression by analyzing the 1 …
[HTML][HTML] Do sociodemographic and clinical factors affect the selection of initial antidepressant treatment for depression in older adults? Results from a nationwide …
K Ishtiak-Ahmed, KS Christensen, C Gasse - Journal of Affective Disorders, 2023 - Elsevier
Background The choice of antidepressants for initial pharmacological treatment of
depression in older adults and associated patients' characteristics are understudied. We …
depression in older adults and associated patients' characteristics are understudied. We …
Is Pilates effective in improving depressive disorders? A comprehensive overview
F Legnani, L Tassi, T Surace, E Capuzzi… - International Clinical …, 2024 - journals.lww.com
Depressive disorders are disabling conditions that account for high social costs. Pilates
demonstrated to have several beneficial effects on health. Objective of this manuscript was …
demonstrated to have several beneficial effects on health. Objective of this manuscript was …
Glial-restricted precursors stimulate endogenous cytogenesis and effectively recover emotional deficits in a model of cytogenesis ablation
J Martins-Macedo, B Araújo, SI Anjo… - Molecular …, 2024 - nature.com
Adult cytogenesis, the continuous generation of newly-born neurons (neurogenesis) and
glial cells (gliogenesis) throughout life, is highly impaired in several neuropsychiatric …
glial cells (gliogenesis) throughout life, is highly impaired in several neuropsychiatric …
[HTML][HTML] Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
L Bartova, G Fugger, M Dold, A Kautzky… - Journal of Affective …, 2023 - Elsevier
Background Serotonin-norepinephrine reuptake inhibitors (SNRIs) are among the most
frequently prescribed antidepressants (ADs) for major depressive disorder (MDD), with an …
frequently prescribed antidepressants (ADs) for major depressive disorder (MDD), with an …
[PDF][PDF] Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117
M Gao, H Ma, T Liu, C Cao, Z Zheng, L Tang, W Gu… - Heliyon, 2023 - cell.com
GW117, a novel derivate compound of agomelatine that acts as both a 5-HT2C receptor
antagonist and a MT1/MT2 receptor agonist, likely underlines the potent antidepressant …
antagonist and a MT1/MT2 receptor agonist, likely underlines the potent antidepressant …
[HTML][HTML] Impulsivity across severe mental disorders: a cross-sectional study of immune markers and psychopharmacotherapy
Background Impulsivity is a transdiagnostic feature linked to severe clinical expression and
a potential target for psychopharmacological strategies. Biological underpinnings are largely …
a potential target for psychopharmacological strategies. Biological underpinnings are largely …
[HTML][HTML] Comparative effectiveness of selective serotonin reuptake inhibitors (SSRIs) for depression in 43,061 older adults with chronic somatic diseases: A Danish …
K Ishtiak-Ahmed, C Rohde, C Otte, C Gasse… - General Hospital …, 2024 - Elsevier
Objective To investigate the comparative effectiveness of commonly used selective
serotonin reuptake inhibitors (SSRIs) for comorbid depression in older adults with chronic …
serotonin reuptake inhibitors (SSRIs) for comorbid depression in older adults with chronic …
[HTML][HTML] The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with …
Since selective serotonin reuptake inhibitors, that are recommended as first-line
antidepressant psychopharmacotherapy for major depressive disorder (MDD), may not be …
antidepressant psychopharmacotherapy for major depressive disorder (MDD), may not be …
[HTML][HTML] The clinical perspective on late-onset depression in European real-world treatment settings
L Bartova, G Fugger, M Dold, A Kautzky… - European …, 2024 - Elsevier
The clinical phenotype of the so-called late-onset depression (LOD) affecting up to 30% of
older adults and yielding heterogeneous manifestations concerning symptoms, severity and …
older adults and yielding heterogeneous manifestations concerning symptoms, severity and …